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Abstract We have previously shown that the two membrane
bound enzymes leukotriene C synthase and microsomal glu-
tathione S-transferase interact in vitro and in vivo. Rat basophilic
leukemia cells and murine mastocytoma cells, two well-known
sources of leukotriene C synthase, both expressed microsomal
glutathione S-transferase as determined by Western blot
analyses. Several human tissues were found to contain both
leukotriene C synthase and microsomal glutathione S-transferase
mRNA. These data suggest that the interaction may be
physiologically important. To study this further, expression
vectors encoding the two enzymes were cotransfected into
mammalian cells and the subcellular localization of the enzymes
was determined by indirect immunofluorescence using confocal
laser scanning microscopy. The results showed that leukotriene C
synthase and microsomal glutathione S-transferase were both
localized on the nuclear envelope and adjacent parts of the
endoplasmic reticulum. Image overlay demonstrated virtually
identical localization. We also observed that coexpression
substantially reduced the catalytic activity of each enzyme
suggesting that a mechanism involving protein^protein inter-
action may contribute to the regulation of LTC4 produc-
tion. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Leukotrienes (LTs) are biologically active compounds de-
rived from arachidonic acid with important functions in in-
£ammation [1,2]. The cysteinyl LT LTC4 is produced by ad-
dition of a glutathione (GSH) moiety to LTA4 catalyzed by
LTC4 synthase (LTCS) [3], a 17 kDa homodimeric microso-
mal protein [4,5]. LTC4 stimulates bronchoconstriction, air-
way mucous production and edema formation in nearly every
vascular bed investigated [6].
Microsomal GSH S-transferase (MGST) is a homotrimeric
18 kDa protein and like other GSH transferases it is involved
in detoxi¢cation and metabolism of xenobiotics [7]. This en-
zyme was shown to bind LTC4 [8] and we have previously
reported a direct protein^protein interaction between MGST
and LTCS in vitro and developed an a⁄nity puri¢cation of
LTCS based on this interaction [9]. We also demonstrated in
vivo interaction between LTCS and MGST using the yeast
two-hybrid system [10]. LTCS and MGST both belong to a
gene family of membrane-associated proteins in eicosanoid
and GSH metabolism (MAPEG) [11].
This paper reports further studies concerning the physiolog-
ical signi¢cance of the interaction between LTCS and MGST.
2. Materials and methods
2.1. Materials
Human RNA Master Blot and express hybridizing solution were
purchased from Clontech. Dulbecco’s modi¢ed Eagle’s medium, fetal
calf serum, antibiotics and competent Escherichia coli DH5K cells
were from Gibco BRL. Restriction enzymes, deep vent DNA poly-
merase and T4 DNA ligase were from New England Biolabs. LTC4
and LTA4 were purchased from Cayman Chemicals Inc. All other
chemicals used were from Sigma. Dr. David Tu kindly provided hu-
man MGST cDNA.
2.2. Antibodies
A monoclonal antibody (M2) raised against the FLAG epitope was
purchased from Kodak, New Haven, CT, USA. Dr. Ralf Morgen-
stern kindly provided rabbit anti-rat MGST antiserum. Fluoro-
chrome-conjugated secondary antibodies, anti-mouse £uorescein iso-
thiocyanate (FITC) a⁄nipure F(abP)2 goat IgG, was from Dakopatts
and anti-rabbit Cy3 a⁄nipure F(abP)2 sheep IgG was from Sigma. A
mouse monoclonal antibody, anti-His6, was from Roche Molecular
Biochemicals and peroxidase-conjugated goat anti-mouse IgG was
from Dakopatts. A⁄nity-puri¢ed [125I]protein A was from Amersham
Pharmacia Biotech.
2.3. Plasmids
Human LTCS cDNA was subcloned into the mammalian expres-
sion vector pcDNA3 (Invitrogen) in frame with an upstream FLAG
epitope. MGST cDNA was subcloned into pcDNA3 without the
FLAG epitope.
2.4. Northern dot blot analysis
LTCS cDNA was labeled with [K-32P]dATP (3 Ci/mmol) by a ran-
dom prime technique. The membrane was prehybridized with express
hybridized solution containing heat-denatured sheared salmon sperm
DNA for 30 min at 65‡C. Approximately 7.5 WCi of denatured probe
was hybridized with the membrane overnight at 65‡C. The membrane
was stringently washed and exposed to X-ray ¢lm for 5 days. The blot
was then stripped by boiling in 0.1% sodium dodecyl sulphate (SDS)
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for 10 min and reprobed with MGST cDNA probe prepared in the
same way.
2.5. Heterologous expression of LTCS and MGST in CV-1 cells
20 Wg of recombinant pcDNA3-LTCS or pcDNA3-MGST plus 20
Wg of empty vector DNA were used to transfect CV-1 cells, grown in
10 cm Petri dishes, using the calcium phosphate precipitation method
[12]. For double transfected cells, 20 Wg of each vector was used
making the total amount of DNA equal in all experiments. Trans-
fected cells were harvested after 48 h and microsomes prepared, re-
suspended in phosphate-bu¡ered saline (PBS) and solubilized with 1%
CHAPS. The solubilized membrane fractions were assayed for enzy-
matic activities.
2.6. Western blotting
CV-1 cells transfected with vectors expressing LTCS or MGST
fused to a His6 C-terminal epitope. Solubilized membrane fractions
were passed through a Ni-NTA-a⁄nity matrix and retained material
was eluted and separated by SDS^PAGE on a 15% slab gel followed
by electrophoretic transfer onto nitrocellulose ¢lter. The nitrocellulose
¢lter was blocked using 3% bovine serum albumin (BSA) in PBS and
incubated with a monoclonal anti-His antibody followed by incuba-
tion with an peroxidase-conjugated anti-mouse goat IgG antibody.
Immunoreactive bands were visualized with chemiluminescence.
Alternatively, CV-1 cells were transfected with vectors expressing
LTCS fused to a C-terminal FLAG epitope or MGST fused to a C-
terminal V5 epitope. Membrane fractions prepared from sonicated
cells by centrifugation at 100 000Ug for 60 min were resuspended in
10 mM Tris^HCl pH 7.6 and separated by SDS^PAGE (15% slab
gels) followed by electrophoretic transfer onto nitrocellulose ¢lter.
The nitrocellulose ¢lter was blocked using 3% BSA in PBS and in-
cubated with monoclonal anti-FLAG antibody followed by peroxi-
dase-conjugated goat anti-mouse IgG. Immunoreactive bands were
visualized by chemiluminescence.
Murine mastocytoma cells (CXBGABMCT-1) were propagated in
CB6F1 mice as described [13]. A membrane fraction was isolated from
homogenized tumors by centrifugation at 100 000Ug for 60 min, re-
suspended in 0.1 M NaPO4 bu¡er, pH 8.06, and separated by SDS^
PAGE (15% slab gel) followed by electrophoretic transfer onto nitro-
cellulose ¢lter. The nitrocellulose ¢lter was blocked using 3% BSA in
PBS and incubated with polyclonal antibody against MGST followed
by a⁄nity-puri¢ed [125I]protein A. Immunoreactive bands were visu-
alized by autoradiography.
Rat basophilic leukemia (RBL-1) cells were cultured and harvested
as described [14] and a membrane fraction was isolated and subjected
to Western blot analyses as described above for murine mastocytoma
cells.
2.7. Protein concentrations
Protein concentrations were determined using the method described
by Bradford [15].
2.8. Assay of MGST activity
MGST enzymatic activity was measured spectrophotometrically at
340 nm using 1-chloro-2,4-dinitrobenzene (CDNB) and reduced GSH
as substrates [16].
2.9. Assay of LTCS activity
LTCS enzymatic activity was measured in microsome preparations
preincubated in 0.1 M sodium phosphate pH 7.0 bu¡er for 1 min
followed by 5 mM GSH for 1 min at 30‡C in 100 Wl reaction volume.
The reaction was started by addition of LTA4 (free acid) to a ¢nal
Fig. 1. Tissue distribution of MGST and LTCS mRNA. The expression pattern of MGST mRNA and LTCS mRNA was studied using North-
ern dot blot analysis. A human RNA Master Blot (Clontech) was prehybridized for 30 min at 65‡C. Approximately 7.5 WCi of denatured ran-
dom 32P-labeled LTCS cDNA probe was hybridized with the membrane overnight at 65‡C. The membrane was stringently washed and subse-
quently subjected to autoradiography. The blot was then stripped by boiling in 0.1% SDS for 10 min and reprobed with MGST cDNA probe
prepared in the same way. The inset shows the presence of MGST in murine mastocytoma (MCT) and RBL-1 cells detected by immunoblot-
ting as described in Section 2.
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concentration of 40 WM and allowed to continue for 15 min at 30‡C.
Addition of 100 Wl of acidi¢ed cold methanol terminated the reaction.
Proteins were precipitated at 320‡C for 1 h and removed by 5000Ug
centrifugation for 10 min. A 150 Wl aliquot of the supernatant was
high performance liquid chromatography-separated on a C18 Nucleo-
sil reverse phase column (4.6U150 mm, 5 Wm particles) using a Hew-
lett Packard model 1090 instrument equipped with a model 1040
diode array detector. The solvent used was methanol, water, acetic
acid and orthophosphoric acid (70:30:0.07:0.03, v/v/v/v) adjusted to
pH 5.6; the £ow rate was 1.0 ml/min. LTC4 formation was quanti¢ed
by the area of the peak at 280 nm in relation to the area of the
injected standard LTC4.
2.10. Indirect immuno£uorescence
CV-1 cells grown in six-well dishes were transiently transfected with
pcDNA3-LTCS cDNA and pcDNA3-MGST cDNA (5 Wg of each
plasmid). After 12 h, the cells were washed and fresh medium was
added. The cells were incubated for an additional 24 h and then ¢xed
in 2% paraformaldehyde in PBS for 45 min. Fixed cells were washed
with PBS and permeabilized with 0.1% Triton X-100 for 10 min.
Rabbit anti-rat MGST antiserum plus monoclonal anti-FLAG anti-
body, M2 (1:50 dilutions in PBS, 1% BSA), were applied for 60 min,
followed by ¢ve washes in PBS, 0.1% BSA. Fluorochrome-conjugated
secondary antibodies (Cy3-labeled sheep anti-rabbit IgG diluted 1:150
plus FITC-labeled goat anti-mouse IgG diluted 1:150) were applied
for 60 min followed by ¢ve more washes.
2.11. Confocal laser scanning microscopy
Fluorescent sections were imaged at an optical magni¢cation of
60U using a Sarastro confocal microscope (Molecular Dynamics,
Sunnyvale, CA, USA) equipped with an argon laser coupled to a
Nikon microscope (Tokyo, Japan).
3. Results
3.1. Tissue distribution of LTCS and MGST
To evaluate the tissue distribution of the two enzymes, we
performed Northern dot blot analyses. The expression of
LTCS mRNA was substantially lower than that of MGST
mRNA (Fig. 1). It was predominantly observed in placenta,
salivary gland, spleen, skeletal muscle, colon, pituitary gland,
uterus, whole brain, thymus and trachea. MGST mRNA ex-
pression was similar to recently published data [17].
3.2. Subcellular distribution of MGST and LTCS
In order to determine the subcellular distribution of LTCS
and MGST, we performed indirect immuno£uorescence anal-
yses on transfected CV-1 cells. Both LTCS and MGST were
mainly membrane bound and the staining in both cases was
especially strong in the nuclear envelope. Fig. 2A shows a
representative cell expressing high levels of transfected
LTCS. Similarly, in Fig. 2B, a representative cell expressing
transfected MGST is shown. When the £uorescence represent-
ing LTCS and MGST, respectively, was superimposed, colo-
calization on the nuclear envelope was evident (Fig. 3C).
3.3. Enzymatic activities of heterologously expressed MGST
and LTCS
In order to investigate if coexpression of LTCS and MGST
would in£uence their ability to catalyze the conjugation of
GSH with xenobiotic compounds (MGST) or LTA4
(LTCS), CV-1 cells were transiently transfected with vectors
Fig. 2. Subcellular distribution of LTCS and MGST protein in CV-1 cells. CV cells were plated on glass coverslips and transfected with vectors
directing the expression of epitope-tagged LTCS (A) or MGST. 24 h later, the cells were ¢xed and prepared for indirect immuno£uorescence
labeling using either an anti-epitope antibody (A) or an anti-IgG antibody (B) followed by chromophore-conjugated secondary antibodies (A:
FITC anti-mouse goat IgG; B: Cy3 anti-rabbit sheep IgG) as described in Section 2. A shows a picture of a representative transfected cell ex-
pressing high levels of LTCS. B shows a picture of representative cells expressing transfected MGST. The immunostaining in A is concentrated
to the nuclear envelope. B shows a similar staining pattern but in addition staining is observed throughout membrane structures throughout
the cytoplasm.
Fig. 3. Colocalization of LTCS and MGST on the nuclear envelope. CV-1 cells were plated on glass coverslips and transfected with epitope-
tagged LTCS and MGST. Cells were harvested 24 h later and immunostained with anti-MGST antiserum followed by Cy3-conjugated sheep
anti-rabbit antibody and monoclonal anti-FLAG antibody (M2) followed by FITC-conjugated goat anti-mouse antibody. Images were collected
using a Sarastro 2000 confocal imaging system linked to a Nikon microscope. The LTCS signal alone is illustrated in A. The MGST signal
from the same optical section is illustrated in B. The sections are merged in C. Regions in which LTCS and MGST colocalize appear yellow.
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directing the expression of LTCS and MGST, respectively.
Homogenate was prepared from these cells and LTCS enzy-
matic activity was measured in microsomes. MGST enzymatic
activity was also assayed in these homogenates. There was a
greater than 50% decrease in LTCS activity when the cells
were transfected with both LTCS and MGST as compared
with LTCS alone (Fig. 4A). A similar e¡ect was observed
when measuring MGST enzymatic activity instead (Fig. 4B).
The diminished LTCS activity was not caused by decreased
enzyme protein expression (Fig. 5).
4. Discussion
In the present study, we compared the tissue distribution of
MGST and LTCS mRNA in order to determine if the earlier
described interaction between these enzymes in vitro and in
vivo has physiological relevance. The distribution of human
MGST mRNA was recently reported [17] and our results were
in agreement with those except for pancreas (which in our
case was 6 10% of liver compared to 103% in [17]), prostate
(V10% of liver compared to 45% in [17]), lung (V50% of
liver compared to 15% in [17]). Human LTCS mRNA levels
were considerably lower than corresponding MGST mRNA.
The highest expression was detected in placenta, spleen, sali-
vary gland, colon and skeletal muscle. Somewhat surprisingly,
LTCS was expressed in comparably low amounts in lung.
Both enzymes were expressed in placenta, colon and brain
in relatively high amounts, and in lower amounts in pituitary
gland, thymus, uterus, lung and trachea.
The subcellular distribution has previously been determined
for cyclooxygenase I (COX1), COX2, 5-lipoxygenase (5-LOX)
and 5-LOX activating protein (FLAP) [18^21]. Often, these
enzymes were found to be located on the nuclear envelope or
in the nuclear matrix [18^21]. The physiological function of
this is not known but recently several eicosanoids have been
recognized as ligands for nuclear receptors [22^24]. In order to
determine the subcellular distribution of LTCS, we performed
indirect immuno£uorescence analyses on transfected epitope-
tagged LTCS in CV-1 cells. The cells showed distinct staining
of the nuclear membrane and less distinct staining on sur-
rounding endoplasmic reticulum, indicating that LTCS is lo-
cated on the nuclear membrane. We also performed indirect
immunostaining of MGST in transfected CV-1 cells. In this
case the nuclear envelope was stained but the staining pattern
was not limited to the nuclear membrane, intense staining was
observed in membrane structures throughout the cells. When
the staining patterns of LTCS and MGST in doubly stained
cells were superimposed using laser-assisted confocal micros-
copy, there was a clear indication of colocalization of LTCS
and MGST on the nuclear envelope.
LTC4, the product of LTCS catalysis, is a strong inhibitor
of MGST [25]. Our ¢nding that LTCS and MGST colocalized
intracellularly led us to investigate the e¡ects of coexistence of
the two enzymes on their catalytic activity. We performed
enzymatic measurements on transfected cells and determined
the e¡ects of coexpressing the other enzyme. When MGST
was cotransfected with LTCS, there was a marked e¡ect on
LTCS resulting in a 50% loss of enzymatic activity. Similarly,
the MGST enzymatic activity as measured with CDNB de-
creased approximately 50% when MGST was coexpressed
Fig. 4. E¡ect of cotransfection of LTCS and MGST on their enzymatic activities. LTCS and MGST activities were measured in a membrane
fraction isolated from homogenates of cells, transiently transfected with vectors directing the expression of LTCS and MGST as indicated.
LTCS activity was markedly decreased when the cells were transfected with both LTCS and MGST as compared with LTCS alone (A). A simi-
lar e¡ect was observed when measuring MGST enzymatic activity (B). The inset shows Western blots of the heterologously expressed LTCS
and MGST in transfected CV-1 cells.
Fig. 5. Expression of LTCS in CV-1 cells cotransfected with
MGST. CV-1 cells were transfected at 50% con£uency with 20 Wg
of a vector encoding C-terminal FLAG epitope tagged LTCS
(pcDNA3-LTCS) plus 20 Wg of empty vector (pcDNA3), or with 20
Wg of a vector encoding C-terminal V5 epitope tagged MGST
(pcDNA3-MGST) plus 20 Wg of empty vector (pcDNA3) or with 20
Wg pcDNA3-LTCS plus 20 Wg pcDNA3-MGST. Cells were har-
vested after 36 h and membrane fractions were prepared. Equal
amounts of protein were loaded in each well and separated by
SDS^PAGE followed by electrophoretic transfer onto nitrocellulose
¢lter. The nitrocellulose ¢lter was blocked using 3% BSA in PBS
and incubated with monoclonal anti-FLAG antibody followed by
incubation with peroxidase-conjugated goat anti-mouse IgG. Immu-
noreactive bands corresponding to LTCS were visualized by chemi-
luminescence.
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with LTCS. The observations that a number of tissues express
both MGST and LTCS, that the two enzymes have virtually
indistinguishable subcellular distribution and inhibit each
others catalytic activity strongly suggest that the protein^pro-
tein interaction between these two GSH conjugating enzymes
contributes to the function of these medically important pro-
teins.
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